Literature DB >> 16219517

Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.

Yao-Lung Chang1, Peter C C Hsieh, Shuenn-Dyh Chang, An-Shine Chao, Ching Chung Liang, Yung-Kuei Soong.   

Abstract

OBJECTIVE: We determined the perinatal outcomes of fetuses with isolated congenital second degree atrioventricular block detected in utero and born to mothers seronegative for anti-SSA/Ro-SSB/La antibodies.
METHODS: Isolated second degree atrioventricular block was defined as second degree atrioventricular block detected in utero without the accompanying structural cardiac anomaly, tachyarrhythmia, non-conducted premature atrial beats or long QT syndrome. We review our own cases and search from Medline using keywords such as atrioventricular block, arrhythmia, bradycardia and congenital to collect cases of congenital isolated second degree atrioventricular block.
RESULTS: Two cases were from our institution and five cases from a Medline search; in total seven cases of isolated second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies were analyzed. Six of the seven fetal arrhythmias reverted to sinus rhythm by delivery and did not recur during the follow-up period. The prognosis of the fetus with isolated second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies is better than that of the fetus with maternal anti-SSA/Ro-SSB/La antibodies or the fetus of congenital long QT syndrome with second degree atrioventricular block detected in utero.
CONCLUSION: The fetus with isolated congenital second degree atrioventricular block carries a good prognosis in the absence of maternal anti-SSA/Ro-SSB/La antibodies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219517     DOI: 10.1016/j.ejogrb.2005.01.013

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  4 in total

1.  Congenital heart block not associated with anti-Ro/La antibodies: comparison with anti-Ro/La-positive cases.

Authors:  Antonio Brucato; Chiara Grava; Maria Bortolati; Keigo Ikeda; Ornella Milanesi; Rolando Cimaz; Veronique Ramoni; Gabriele Vignati; Stefano Martinelli; Youcef Sadou; Adele Borghi; Angela Tincani; Edward K L Chan; Amelia Ruffatti
Journal:  J Rheumatol       Date:  2009-06-30       Impact factor: 4.666

2.  Maternal Anti-Ro/SSA and Anti-La/SSB Antibodies and Fetal Congenital Heart Block.

Authors:  Anupam Kapur; Madhusudan Dey; Manoj Tangri; H C Bandhu
Journal:  J Obstet Gynaecol India       Date:  2014-11-20

Review 3.  Overview of fetal arrhythmias.

Authors:  Shardha Srinivasan; Janette Strasburger
Journal:  Curr Opin Pediatr       Date:  2008-10       Impact factor: 2.856

4.  Remission of congenital complete heart block without anti-Ro/La antibodies: A case report.

Authors:  Souvik Mitra; Anindya Kumar Saha; Syamal Kumar Sardar; Arun Kumarendu Singh
Journal:  Ann Pediatr Cardiol       Date:  2013-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.